9-28 | Governments must now turn words on paper into practice and take the necessary steps to save more lives of people with TB.
9-19 | Ahead of the global tuberculosis High-Level Meeting at the United Nations, MSF calls on Johnson & Johnson not to enforce any secondary patents for bedaquiline in any country with a high burden of TB.We also call on Cepheid to drop the price of the GeneXpert TB test from US$10 to US$5 in order to save lives.
5-17 | Kiribati is one of the most remote and geographically dispersed countries in the world. It is also one of the most vulnerable countries to the impacts of the climate crisis. The country faces has described as a triple threat to health: communicable diseases, non-communicable diseases (NCDs), and the health impacts of climate change.
5-17 | Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB-PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi drug-resistant tuberculosis (MDR-TB), the World Health Organization (WHO) have announced it will update global guidance on treatment. Following the results of MSF’s trial the WHO are now recommending programmatic use of the 6- month BPaLM regimen – comprising bedaquiline, pretomanid, linezolid (600 mg) and moxifloxacin in MDR-TB patients in pla
11-4 | Following the release of US pharmaceutical company Moderna’s astronomical third quarter 2021 sales figures from its only product, the COVID-19 vaccine, Médecins Sans Frontières/Doctors Without Borders (MSF) urged the company to immediately share its mRNA vaccine technology and know-how through the World Health Organization's (WHO) COVID-19 mRNA vaccine technology transfer Hub in South Africa.